Veeva Systems (NYSE:VEEV) Issues Earnings Results

Veeva Systems (NYSE:VEEV) released its earnings results on Wednesday. The technology company reported $2.24 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $2.14 by $0.10, FiscalAI reports. The company had revenue of $882.95 million for the quarter, compared to analyst estimates of $857.73 million. Veeva Systems had a net margin of 28.44% and a return on equity of 13.80%. The firm’s quarterly revenue was up 16.3% on a year-over-year basis. During the same period in the prior year, the business earned $1.97 EPS. Veeva Systems updated its FY 2027 guidance to 9.050-9.050 EPS and its Q2 2027 guidance to 2.210-2.220 EPS.

Here are the key takeaways from Veeva Systems’ conference call:

• Veeva said it had a strong start to the year, with Q1 revenue of $883 million and non-GAAP operating income of $395 million, both ahead of guidance.
• The company is leaning heavily into Falcon and its broader MAP architecture (models, agents, applications), positioning AI agents to perform standardized life sciences labor such as document processing, safety case triage, and regulatory correspondence.
• Vault CRM momentum remains strong, with over 150 customers live, more than 40 migrations completed, and a stated win rate above 80% in the top 20 pharma account set.
• Veeva highlighted continued strength in Crossix, citing innovation in new measurement channels and durable market share gains in a healthy digital advertising market for pharma.
• The newly acquired Ostro business is being run as a startup within Veeva and is expected to contribute about $10 million in the remaining three quarters of the year, with management describing it as additive rather than cannibalistic to the core business.

Veeva Systems Stock Performance

Shares of Veeva Systems stock opened at $178.69 on Thursday. The company has a market capitalization of $29.19 billion, a P/E ratio of 33.03, a PEG ratio of 0.81 and a beta of 0.95. The company’s fifty day moving average is $166.29 and its two-hundred day moving average is $196.71. Veeva Systems has a 1 year low of $148.05 and a 1 year high of $310.50.

Wall Street Analysts Forecast Growth

A number of equities research analysts have issued reports on VEEV shares. Piper Sandler reduced their target price on shares of Veeva Systems from $355.00 to $285.00 and set an “overweight” rating on the stock in a report on Thursday, March 5th. Raymond James Financial reiterated an “outperform” rating and set a $225.00 target price on shares of Veeva Systems in a report on Thursday. Zacks Research lowered shares of Veeva Systems from a “strong-buy” rating to a “hold” rating in a report on Thursday, May 14th. JPMorgan Chase & Co. reduced their price objective on shares of Veeva Systems from $330.00 to $296.00 and set an “overweight” rating on the stock in a report on Friday, February 20th. Finally, UBS Group raised their price objective on shares of Veeva Systems from $200.00 to $220.00 and gave the company a “neutral” rating in a report on Thursday, March 5th. Seventeen research analysts have rated the stock with a Buy rating, eight have issued a Hold rating and one has given a Sell rating to the company. According to MarketBeat, the stock presently has an average rating of “Moderate Buy” and a consensus target price of $271.52.

Trending Headlines about Veeva Systems

Here are the key news stories impacting Veeva Systems this week:

• Positive Sentiment: Veeva reported Q1 revenue of about $882.9 million and adjusted EPS of $2.24, both ahead of estimates, showing continued demand and profitability improvement. Veeva Systems (VEEV) Q1 Earnings and Revenues Surpass Estimates
• Positive Sentiment: Management issued Q2 revenue guidance of roughly $902 million-$905 million and EPS guidance of $2.21-$2.22, both above consensus, signaling confidence in near-term growth. Veeva Announces Fiscal 2027 First Quarter Results
• Positive Sentiment: Veeva highlighted AI innovations during the earnings call, which may support future product adoption and help the company deepen its competitive position in life sciences software. Veeva Systems Inc (VEEV) Q1 2027 Earnings Call Highlights: Surpassing Revenue Guidance and Unveiling AI Innovations
• Neutral Sentiment: Several summaries of the results emphasized that the quarter’s headline numbers were strong, but investors are still parsing the full transcript and details behind the outlook. Veeva Systems Inc. (VEEV) Q1 2027 Earnings Call Transcript
• Negative Sentiment: Despite the beat-and-raise report, some coverage noted the shares slipped after the announcement, suggesting the market may have been positioned for strong results or is focused on valuation and broader market sentiment. Veeva Shares Slip Despite Beating Q1 Estimates: Details

Insider Buying and Selling at Veeva Systems

In other news, Director Priscilla Hung sold 750 shares of Veeva Systems stock in a transaction dated Thursday, April 30th. The shares were sold at an average price of $155.64, for a total value of $116,730.00. Following the sale, the director owned 3,253 shares of the company’s stock, valued at $506,296.92. The trade was a 18.74% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. 10.60% of the stock is currently owned by insiders.

Hedge Funds Weigh In On Veeva Systems

A number of institutional investors have recently modified their holdings of the company. Invesco Ltd. raised its position in shares of Veeva Systems by 12.5% in the fourth quarter. Invesco Ltd. now owns 323,302 shares of the technology company’s stock valued at $72,171,000 after buying an additional 35,832 shares during the last quarter. Corient Private Wealth LLC raised its position in shares of Veeva Systems by 33.4% in the fourth quarter. Corient Private Wealth LLC now owns 196,746 shares of the technology company’s stock valued at $43,920,000 after buying an additional 49,279 shares during the last quarter. EP Wealth Advisors LLC purchased a new stake in Veeva Systems in the fourth quarter valued at approximately $942,000. Coastal Bridge Advisors LLC grew its holdings in Veeva Systems by 47.3% in the fourth quarter. Coastal Bridge Advisors LLC now owns 1,022 shares of the technology company’s stock valued at $228,000 after purchasing an additional 328 shares during the period. Finally, Cim LLC grew its holdings in Veeva Systems by 2.6% in the fourth quarter. Cim LLC now owns 5,712 shares of the technology company’s stock valued at $1,275,000 after purchasing an additional 146 shares during the period. Institutional investors and hedge funds own 88.20% of the company’s stock.

Veeva Systems Company Profile

Veeva Systems (NYSE: VEEV) is a cloud software company that develops industry-specific applications and data solutions for the global life sciences sector. Founded in 2007 and headquartered in Pleasanton, California, Veeva focuses on helping pharmaceutical, biotechnology, medical device and consumer health companies manage regulated content, clinical and regulatory processes, quality systems, and commercial operations in a compliant, cloud-native environment. The company completed its initial public offering in 2013 and has since expanded its product suite and international footprint.

Veeva’s product portfolio centers on its Vault platform and related application suites, which provide content and data management, clinical trial and regulatory workflows, quality management, and structured commercial capabilities such as customer relationship management and promotional content management.